메뉴 건너뛰기




Volumn 33, Issue 4, 2013, Pages 213-223

The bile acid membrane receptor TGR5: A novel pharmacological target in metabolic, inflammatory and neoplastic disorders

Author keywords

Carcinogenesis; Inflammation; Liver function; Metabolic syndrome; TGR5

Indexed keywords

BILE ACID; BILE ACID SEQUESTRANT; CIPROFLOXACIN; COLESEVELAM; COLESTILAN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INCRETIN; LOW DENSITY LIPOPROTEIN; QUINAZOLINONE DERIVATIVE; QUINOLINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TGR5 PROTEIN; UNCLASSIFIED DRUG; CYCLIC AMP; GPBAR1 PROTEIN, HUMAN;

EID: 84880907693     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2013.802805     Document Type: Article
Times cited : (72)

References (110)
  • 1
    • 84875255442 scopus 로고    scopus 로고
    • Bile acids in the colon, from healthy to cytotoxic molecules
    • Barrasa JI, Olmo N, Lizarbe MA, Turnay J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 2013; 27:964-77
    • (2013) Toxicol In Vitro , vol.27 , pp. 964-977
    • Barrasa, J.I.1    Olmo, N.2    Lizarbe, M.A.3    Turnay, J.4
  • 2
    • 66349134159 scopus 로고    scopus 로고
    • Fifty years of advances in bile acid synthesis and metabolism
    • Russell DW. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res 2009;50:S120-5
    • (2009) J Lipid Res , vol.50
    • Russell, D.W.1
  • 3
    • 33751518532 scopus 로고    scopus 로고
    • Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents
    • Mikov M, Fawcett JP, Kuhajda K, Kevresan S. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. Eur J Drug Metab Pharmacokinet 2006;31:237-51
    • (2006) Eur J Drug Metab Pharmacokinet , vol.31 , pp. 237-251
    • Mikov, M.1    Fawcett, J.P.2    Kuhajda, K.3    Kevresan, S.4
  • 4
    • 85044693973 scopus 로고    scopus 로고
    • The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease
    • Stojancevic M, Stankov K, Mikov M. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease. Can J Gastroenterol 2012;6:631-7
    • (2012) Can J Gastroenterol , vol.6 , pp. 631-637
    • Stojancevic, M.1    Stankov, K.2    Mikov, M.3
  • 5
    • 84865540426 scopus 로고    scopus 로고
    • Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bileacid synthesis in mice
    • Kong B, Wang L, Chiang JY, et al. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bileacid synthesis in mice. Hepatology 2012;56:1034-43
    • (2012) Hepatology , vol.56 , pp. 1034-1043
    • Kong, B.1    Wang, L.2    Chiang, J.Y.3
  • 7
    • 48749113401 scopus 로고    scopus 로고
    • Targeting bile-Acid signalling for metabolic diseases
    • Thomas C, Pellicciari R, Pruzanski M, et al. Targeting bile-Acid signalling for metabolic diseases. Nat Rev Drug Discov 2008;7: 678-93
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 678-693
    • Thomas, C.1    Pellicciari, R.2    Pruzanski, M.3
  • 8
    • 78650788593 scopus 로고    scopus 로고
    • The mammalian orphan nuclear receptors: Orphans as cellular guardians
    • Ranhotra HS. The mammalian orphan nuclear receptors: Orphans as cellular guardians. J Recept Signal Transduct Res 2011;31:20-5
    • (2011) J Recept Signal Transduct Res , vol.31 , pp. 20-25
    • Ranhotra, H.S.1
  • 9
    • 33751516329 scopus 로고    scopus 로고
    • International union of pharmacology LXII The NR1H and NR1I receptors: Constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor
    • Moore DD, Kato S, Xie W, et al. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: Constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev 2006;58: 742-59
    • (2006) Pharmacol Rev , vol.58 , pp. 742-759
    • Moore, D.D.1    Kato, S.2    Xie, W.3
  • 10
    • 0003269455 scopus 로고    scopus 로고
    • A G protein-coupled receptor responsive to bile acids
    • Kawamata Y, Fujii R, Hosoya M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435-40
    • (2003) J Biol Chem , vol.278 , pp. 9435-9440
    • Kawamata, Y.1    Fujii, R.2    Hosoya, M.3
  • 11
    • 0043202882 scopus 로고    scopus 로고
    • Activation of muscarinic receptor signaling by bile acids: Physiological and medical implications
    • Raufman JP, Cheng K, Zimniak P. Activation of muscarinic receptor signaling by bile acids: Physiological and medical implications. Dig Dis Sci 2003;48:1431-44
    • (2003) Dig Dis Sci , vol.48 , pp. 1431-1444
    • Raufman, J.P.1    Cheng, K.2    Zimniak, P.3
  • 13
    • 79959525960 scopus 로고    scopus 로고
    • The bile acid membrane receptor TGR5: A valuable metabolic target
    • Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5: A valuable metabolic target. Dig Dis 2011;29: 37-44
    • (2011) Dig Dis , vol.29 , pp. 37-44
    • Pols, T.W.1    Noriega, L.G.2    Nomura, M.3
  • 14
    • 58249110568 scopus 로고    scopus 로고
    • Role of bile acids and bile acid receptors in metabolic regulation
    • Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-91
    • (2009) Physiol Rev , vol.89 , pp. 147-191
    • Lefebvre, P.1    Cariou, B.2    Lien, F.3
  • 15
    • 70350292362 scopus 로고    scopus 로고
    • Bile-Acidactivated receptors: Targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
    • Fiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile-Acidactivated receptors: Targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 2009;30:570-80
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 570-580
    • Fiorucci, S.1    Mencarelli, A.2    Palladino, G.3    Cipriani, S.4
  • 16
    • 0036432845 scopus 로고    scopus 로고
    • Identification of membrane-Type receptor for bile acids (M-BAR
    • Maruyama T, Miyamoto Y, Nakamura T, et al. Identification of membrane-Type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 2002;298:714-9
    • (2002) Biochem Biophys Res Commun , vol.298 , pp. 714-719
    • Maruyama, T.1    Miyamoto, Y.2    Nakamura, T.3
  • 17
    • 84868360297 scopus 로고    scopus 로고
    • Perspective: TGR5 (Gpbar-1) in liver physiology and disease
    • Keitel V, Häussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol 2012;36: 412-9
    • (2012) Clin Res Hepatol Gastroenterol , vol.36 , pp. 412-419
    • Keitel, V.1    Häussinger, D.2
  • 18
    • 78649386642 scopus 로고    scopus 로고
    • The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
    • Keitel V, Görg B, Bidmon HJ, et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 2010;58: 1794-805
    • (2010) Glia , vol.58 , pp. 1794-1805
    • Keitel, V.1    Görg, B.2    Bidmon, H.J.3
  • 19
    • 80052220468 scopus 로고    scopus 로고
    • Advances in bile acid medicinal chemistry
    • Sharma R, Long A, Gilmer JF. Advances in bile acid medicinal chemistry. Curr Med Chem 2011;18:4029-52
    • (2011) Curr Med Chem , vol.18 , pp. 4029-4052
    • Sharma, R.1    Long, A.2    Gilmer, J.F.3
  • 21
    • 84867574634 scopus 로고    scopus 로고
    • Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease
    • Zarrinpar A, Loomba R. Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2012;36:909-21
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 909-921
    • Zarrinpar, A.1    Loomba, R.2
  • 22
    • 84857932052 scopus 로고    scopus 로고
    • Role of microRNAs in diabetes and its cardiovascular complications
    • Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012;93:583-93
    • (2012) Cardiovasc Res , vol.93 , pp. 583-593
    • Shantikumar, S.1    Caporali, A.2    Emanueli, C.3
  • 23
    • 34248223285 scopus 로고    scopus 로고
    • Biology of incretins: GLP-1 and GIP
    • Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57
    • (2007) Gastroenterology , vol.132 , pp. 2131-2157
    • Baggio, L.L.1    Drucker, D.J.2
  • 24
    • 67651173077 scopus 로고    scopus 로고
    • Incretin-based therapies for type 2 diabetes mellitus
    • Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009;5:262-9
    • (2009) Nat Rev Endocrinol , vol.5 , pp. 262-269
    • Lovshin, J.A.1    Drucker, D.J.2
  • 25
    • 77952315531 scopus 로고    scopus 로고
    • Addition of incretin therapy to metformin in type 2 diabetes
    • Scheen AJ, Radermecker RP. Addition of incretin therapy to metformin in type 2 diabetes. The Lancet 2010;375:1410-12
    • (2010) Lancet , vol.375 , pp. 1410-1412
    • Scheen, A.J.1    Radermecker, R.P.2
  • 26
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3: 153-65
    • (2006) Cell Metab , vol.3 , pp. 153-165
    • Drucker, D.J.1
  • 27
    • 13844299425 scopus 로고    scopus 로고
    • Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
    • Katsuma S, Hirasawa A, Tsujimoto G Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005;329:386-90
    • (2005) Biochem Biophys Res Commun , vol.329 , pp. 386-390
    • Katsuma, S.1    Hirasawa, A.2    Tsujimoto, G.3
  • 28
    • 69149083245 scopus 로고    scopus 로고
    • TGR5-mediated bile acid sensing controls glucose homeostasis
    • Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009;10: 167-77
    • (2009) Cell Metab , vol.10 , pp. 167-177
    • Thomas, C.1    Gioiello, A.2    Noriega, L.3
  • 29
    • 39449124119 scopus 로고    scopus 로고
    • Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism
    • Thomas C, Auwerx J, Schoonjans K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008;18:167-74
    • (2008) Thyroid , vol.18 , pp. 167-174
    • Thomas, C.1    Auwerx, J.2    Schoonjans, K.3
  • 30
    • 84861682490 scopus 로고    scopus 로고
    • TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
    • Harach T, Pols TW, Nomura M, et al. TGR5 potentiates GLP-1 secretion in response to anionic exchange resins. Sci Rep 2012; 2:430
    • (2012) Sci Rep , vol.2 , pp. 430
    • Harach, T.1    Pols, T.W.2    Nomura, M.3
  • 31
    • 77956399106 scopus 로고    scopus 로고
    • GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N-And L-Type Ca2 channel-dependent exocytosis
    • De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N-And L-Type Ca2 channel-dependent exocytosis. Cell Metab 2010;11:543-53
    • (2010) Cell Metab , vol.11 , pp. 543-553
    • De Marinis, Y.Z.1    Salehi, A.2    Ward, C.E.3
  • 32
    • 77953403465 scopus 로고    scopus 로고
    • Bile-induced secretion of glucagon-like peptide-1 pathophysiological implications in type 2 diabetes?
    • Knop FK. Bile-induced secretion of glucagon-like peptide-1: Pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 2010;299:E10-13
    • (2010) Am J Physiol Endocrinol Metab , vol.299
    • Knop, F.K.1
  • 33
    • 79961165599 scopus 로고    scopus 로고
    • Current and future drug targets in weight management
    • Witkamp RF. Current and Future Drug Targets in Weight Management. Pharm Res 2011;28:1792-818
    • (2011) Pharm Res , vol.28 , pp. 1792-1818
    • Witkamp, R.F.1
  • 34
    • 34447568475 scopus 로고    scopus 로고
    • Incretin-based therapies: Mimetics versus protease inhibitors
    • Brubaker PL. Incretin-based therapies: Mimetics versus protease inhibitors. Trends Endocrinol Metab 2007;18:240-5
    • (2007) Trends Endocrinol Metab , vol.18 , pp. 240-245
    • Brubaker, P.L.1
  • 35
    • 77953962428 scopus 로고    scopus 로고
    • Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-Alcoholic fatty liver disease
    • Pols TW, Auwerx J, Schoonjans K. Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-Alcoholic fatty liver disease. Gastroenterol Clin Biol 2010;34:270-3
    • (2010) Gastroenterol Clin Biol , vol.34 , pp. 270-273
    • Pols, T.W.1    Auwerx, J.2    Schoonjans, K.3
  • 36
    • 79956088562 scopus 로고    scopus 로고
    • The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
    • Pols TW, Noriega LG, Nomura M, et al. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 2011;54:1263-72
    • (2011) J Hepatol , vol.54 , pp. 1263-1272
    • Pols, T.W.1    Noriega, L.G.2    Nomura, M.3
  • 37
    • 31444454037 scopus 로고    scopus 로고
    • Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
    • Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484-9
    • (2006) Nature , vol.439 , pp. 484-489
    • Watanabe, M.1    Houten, S.M.2    Mataki, C.3
  • 38
    • 76549086983 scopus 로고    scopus 로고
    • Bile acid-Activated receptors in the treatment of dyslipidemia and related disorders
    • Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acid-Activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 2010;49:171-85
    • (2010) Prog Lipid Res , vol.49 , pp. 171-185
    • Fiorucci, S.1    Cipriani, S.2    Baldelli, F.3    Mencarelli, A.4
  • 39
    • 33751066787 scopus 로고    scopus 로고
    • Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
    • Maruyama T, Tanaka K, Suzuki J, et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol 2006;191:197-205
    • (2006) J Endocrinol , vol.191 , pp. 197-205
    • Maruyama, T.1    Tanaka, K.2    Suzuki, J.3
  • 40
    • 77952562273 scopus 로고    scopus 로고
    • Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
    • Vassileva G, Hu W, Hoos L, et al. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. J Endocrinol 2010;205:225-32
    • (2010) J Endocrinol , vol.205 , pp. 225-232
    • Vassileva, G.1    Hu, W.2    Hoos, L.3
  • 41
    • 77956455354 scopus 로고    scopus 로고
    • Plasma bile acids are not associated with energy metabolism in humans
    • Brufau G, Bahr MJ, Staels B, et al. Plasma bile acids are not associated with energy metabolism in humans. Nutr Metab (Lond) 2010;7:73
    • (2010) Nutr Metab (Lond , vol.7 , pp. 73
    • Brufau, G.1    Bahr, M.J.2    Staels, B.3
  • 42
    • 84867867477 scopus 로고    scopus 로고
    • The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation
    • Tornatore L, Thotakura AK, Bennett J, et al. The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation. Trends Cell Biol 2012;22:557-66
    • (2012) Trends Cell Biol , vol.22 , pp. 557-566
    • Tornatore, L.1    Thotakura, A.K.2    Bennett, J.3
  • 43
    • 77951918926 scopus 로고    scopus 로고
    • Macrophages, inflammation, and insulin resistance
    • Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46
    • (2010) Annu Rev Physiol , vol.72 , pp. 219-246
    • Olefsky, J.M.1    Glass, C.K.2
  • 44
    • 4644324186 scopus 로고    scopus 로고
    • NF-kappaB functions as a tumour promoter in inflammation-Associated cancer
    • Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-Associated cancer. Nature 2004; 431:461-6
    • (2004) Nature , vol.431 , pp. 461-466
    • Pikarsky, E.1    Porat, R.M.2    Stein, I.3
  • 45
    • 77349087078 scopus 로고    scopus 로고
    • SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
    • Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 2010;298: E419-28
    • (2010) Am J Physiol Endocrinol Metab , vol.298
    • Yoshizaki, T.1    Schenk, S.2    Imamura, T.3
  • 46
    • 0026657890 scopus 로고
    • Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-Alpha production by monocytes
    • Calmus Y, Guechot J, Podevin P, et al. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-Alpha production by monocytes. Hepatology 1992;16:719-23
    • (1992) Hepatology , vol.16 , pp. 719-723
    • Calmus, Y.1    Guechot, J.2    Podevin, P.3
  • 47
    • 44649092024 scopus 로고    scopus 로고
    • Expression and function of the bile acid receptor TGR5 in Kupffer cells
    • Keitel V, Donner M, Winandy S, et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 2008;372:78-84
    • (2008) Biochem Biophys Res Commun , vol.372 , pp. 78-84
    • Keitel, V.1    Donner, M.2    Winandy, S.3
  • 48
    • 84864861866 scopus 로고    scopus 로고
    • Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
    • Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 2012;53:1723-37
    • (2012) J Lipid Res , vol.53 , pp. 1723-1737
    • Porez, G.1    Prawitt, J.2    Gross, B.3    Staels, B.4
  • 49
    • 84864133462 scopus 로고    scopus 로고
    • Cellular and molecular players in the atherosclerotic plaque progression
    • Businaro R, Tagliani A, Buttari B, et al. Cellular and molecular players in the atherosclerotic plaque progression. Ann N YAcad Sci 2012;1262:134-41
    • (2012) Ann N YAcad Sci , vol.1262 , pp. 134-141
    • Businaro, R.1    Tagliani, A.2    Buttari, B.3
  • 50
    • 75749148425 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis: Transition from theory to practice
    • Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010;74: 213-20
    • (2010) Circ J , vol.74 , pp. 213-220
    • Libby, P.1    Okamoto, Y.2    Rocha, V.Z.3    Folco, E.4
  • 51
    • 84866318436 scopus 로고    scopus 로고
    • Macrophage proliferation and apoptosis in atherosclerosis
    • Andrés V, Pello OM, Silvestre-Roig C. Macrophage proliferation and apoptosis in atherosclerosis. Curr Opin Lipidol 2012;23: 429-38
    • (2012) Curr Opin Lipidol , vol.23 , pp. 429-438
    • Andrés, V.1    Pello, O.M.2    Silvestre-Roig, C.3
  • 52
    • 69249205739 scopus 로고    scopus 로고
    • Obesity, inflammation, and atherosclerosis
    • Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009;6:399-409
    • (2009) Nat Rev Cardiol , vol.6 , pp. 399-409
    • Rocha, V.Z.1    Libby, P.2
  • 53
    • 82955168360 scopus 로고    scopus 로고
    • TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading
    • Pols TWH, Nomura M, Harach T, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 2011;14:747-57
    • (2011) Cell Metab , vol.14 , pp. 747-757
    • Pols, T.W.H.1    Nomura, M.2    Harach, T.3
  • 54
    • 0030949830 scopus 로고    scopus 로고
    • Inhibition of tumor necrosis factor-Alpha and interleukin-1-beta production by beta-Adrenoreceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells
    • Yoshimura T, Kurita C, Nagao T, et al. Inhibition of tumor necrosis factor-Alpha and interleukin-1-beta production by beta-Adrenoreceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 1997;54:144-52
    • (1997) Pharmacology , vol.54 , pp. 144-152
    • Yoshimura, T.1    Kurita, C.2    Nagao, T.3
  • 55
    • 78650878363 scopus 로고    scopus 로고
    • NF-kB, inflammation, and metabolic disease
    • Baker RG, Hayden MS, Ghosh S. NF-kB, inflammation, and metabolic disease. Cell Metab 2011;13:11-22
    • (2011) Cell Metab , vol.13 , pp. 11-22
    • Baker, R.G.1    Hayden, M.S.2    Ghosh, S.3
  • 56
    • 4544342570 scopus 로고    scopus 로고
    • Nuclear factor-kappaB: The enemy within
    • Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004;6:203-8
    • (2004) Cancer Cell , vol.6 , pp. 203-208
    • Aggarwal, B.B.1
  • 57
    • 80053308007 scopus 로고    scopus 로고
    • The g-protein-coupled bile acid receptor gpbar1 (tgr5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor k light-chain enhancer of activated b cells (nf-kb) in mice
    • Wang YD, Chen WD, Yu D, et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor k light-chain enhancer of activated B cells (NF-kB) in mice. Hepatology 2011; 54:1421-32
    • (2011) Hepatology , vol.54 , pp. 1421-1432
    • Wang, Y.D.1    Chen, W.D.2    Yu, D.3
  • 58
    • 34248209613 scopus 로고    scopus 로고
    • Macrophage-specific inhibition of NF-kappaB activation reduces foam cell formation
    • Ferreira V, van Dijk KW, Groen AK, et al. Macrophage-specific inhibition of NF-kappaB activation reduces foam cell formation. Atherosclerosis 2007;192:283-90
    • (2007) Atherosclerosis , vol.192 , pp. 283-290
    • Ferreira, V.1    Van Dijk, K.W.2    Groen, A.K.3
  • 59
    • 80055090450 scopus 로고    scopus 로고
    • The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis
    • Cipriani S, Mencarelli A, Chini MG, et al. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One 2011;6: E25637
    • (2011) PLoS One , vol.6
    • Cipriani, S.1    Mencarelli, A.2    Chini, M.G.3
  • 60
    • 0030036174 scopus 로고    scopus 로고
    • Biliary decompression promotes Kupffer cell recovery in obstructive jaundice
    • Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925-31
    • (1996) Gut , vol.38 , pp. 925-931
    • Clements, W.D.1    McCaigue, M.2    Erwin, P.3
  • 61
    • 67349205002 scopus 로고    scopus 로고
    • Kupffer cells in non-Alcoholic fatty liver disease: The emerging view
    • Baffy G. Kupffer cells in non-Alcoholic fatty liver disease: The emerging view. J Hepatol 2009;51:212-23
    • (2009) J Hepatol , vol.51 , pp. 212-223
    • Baffy, G.1
  • 62
    • 0033053956 scopus 로고    scopus 로고
    • Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids
    • Sung JJ, Go MY. Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids. J Hepatol 1999;30: 413-8
    • (1999) J Hepatol , vol.30 , pp. 413-418
    • Sung, J.J.1    Go, M.Y.2
  • 63
    • 0025304385 scopus 로고
    • The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat
    • Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990;10:274-9
    • (1990) J Hepatol , vol.10 , pp. 274-279
    • Van Bossuyt, H.1    Desmaretz, C.2    Gaeta, G.B.3    Wisse, E.4
  • 64
    • 0027768854 scopus 로고
    • Impaired bacterial killing in early obstructive jaundice
    • Scott-Conner CE, Grogan JB, Scher KS, et al. Impaired bacterial killing in early obstructive jaundice. Am J Surg 1993;166:308-10
    • (1993) Am J Surg , vol.166 , pp. 308-310
    • Scott-Conner, C.E.1    Grogan, J.B.2    Scher, K.S.3
  • 65
    • 0025138309 scopus 로고
    • Obstructive jaundice promotes bacterial translocation from the gut
    • Deitch EA, Sittig K, Li M, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159: 79-84
    • (1990) Am J Surg , vol.159 , pp. 79-84
    • Deitch, E.A.1    Sittig, K.2    Li, M.3
  • 66
    • 25844459154 scopus 로고    scopus 로고
    • Nf-Kappa B linking inflammation and immunity to cancer development and progression
    • Karin M, Greten FR. NF-kappa B; linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-59
    • (2005) Nat Rev Immunol , vol.5 , pp. 749-759
    • Karin, M.1    Greten, F.R.2
  • 67
    • 33947383769 scopus 로고    scopus 로고
    • The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
    • Keitel V, Reinehr R, Gatsios P, et al. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 2007;45:695-704
    • (2007) Hepatology , vol.45 , pp. 695-704
    • Keitel, V.1    Reinehr, R.2    Gatsios, P.3
  • 68
    • 77957756211 scopus 로고    scopus 로고
    • Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells
    • Cheluvappa R, Denning GM, Lau GW, et al. Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. Int J Infect Dis 2010;14:e857-67
    • (2010) Int J Infect Dis , vol.14
    • Cheluvappa, R.1    Denning, G.M.2    Lau, G.W.3
  • 69
    • 27544516123 scopus 로고    scopus 로고
    • Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins
    • Duryee MJ, Freeman TL, Willis MS, et al. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol 2005;68:1423-30
    • (2005) Mol Pharmacol , vol.68 , pp. 1423-1430
    • Duryee, M.J.1    Freeman, T.L.2    Willis, M.S.3
  • 70
    • 0345714699 scopus 로고    scopus 로고
    • Control of immune responses by scavenger liver endothelial cells
    • Knolle PA, Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly 2003;133:501-6
    • (2003) Swiss Med Wkly , vol.133 , pp. 501-506
    • Knolle, P.A.1    Limmer, A.2
  • 71
    • 17844403220 scopus 로고    scopus 로고
    • Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis
    • Keitel V, Burdelski M, Warskulat U, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005;41:1160-72
    • (2005) Hepatology , vol.41 , pp. 1160-1172
    • Keitel, V.1    Burdelski, M.2    Warskulat, U.3
  • 72
    • 0347361545 scopus 로고    scopus 로고
    • Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95
    • Reinehr R, Häussinger D Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology 2004;126:249-62
    • (2004) Gastroenterology , vol.126 , pp. 249-262
    • Reinehr, R.1    Häussinger, D.2
  • 73
    • 84856081407 scopus 로고    scopus 로고
    • CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration
    • Reinehr R, Häussinger D. CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration. Arch Biochem Biophys 2012;518:2-7
    • (2012) Arch Biochem Biophys , vol.518 , pp. 2-7
    • Reinehr, R.1    Häussinger, D.2
  • 74
    • 0037621928 scopus 로고    scopus 로고
    • The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice
    • Theodorakis NG, Wang YN, Skill NJ, et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: Studies in gene-knockout mice. Gastroenterology 2003;124:1500-8
    • (2003) Gastroenterology , vol.124 , pp. 1500-1508
    • Theodorakis, N.G.1    Wang, Y.N.2    Skill, N.J.3
  • 75
    • 35848962696 scopus 로고    scopus 로고
    • The molecules: Mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension
    • Iwakiri Y. The molecules: Mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension. J Clin Gastroenterol 2007;41:S288-94
    • (2007) J Clin Gastroenterol , vol.41
    • Iwakiri, Y.1
  • 76
    • 70349733124 scopus 로고    scopus 로고
    • Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model
    • Theodorakis NG, Wang YN, Wu JM, et al. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. Am J Physiol Gastrointest Liver Physiol 2009;297:G792-9
    • (2009) Am J Physiol Gastrointest Liver Physiol , vol.297
    • Theodorakis, N.G.1    Wang, Y.N.2    Wu, J.M.3
  • 77
    • 79961183211 scopus 로고    scopus 로고
    • Identification of circulatory and excretory metabolites of a novel nitric oxide donor ZJM-289 in rat plasma, bile, urine and faeces by liquid chromatography-Tandem mass spectrometry
    • Li N, Wang X, Li T, et al. Identification of circulatory and excretory metabolites of a novel nitric oxide donor ZJM-289 in rat plasma, bile, urine and faeces by liquid chromatography-Tandem mass spectrometry. Xenobiotica 2011;41:805-17
    • (2011) Xenobiotica , vol.41 , pp. 805-817
    • Li, N.1    Wang, X.2    Li, T.3
  • 78
    • 70349255713 scopus 로고    scopus 로고
    • The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
    • Keitel V, Cupisti K, Ullmer C, et al. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 2009;50:861-70
    • (2009) Hepatology , vol.50 , pp. 861-870
    • Keitel, V.1    Cupisti, K.2    Ullmer, C.3
  • 79
    • 77954569180 scopus 로고    scopus 로고
    • The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
    • Keitel V, Ullmer C, Häussinger D. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem 2010;391:785-9
    • (2010) Biol Chem , vol.391 , pp. 785-789
    • Keitel, V.1    Ullmer, C.2    Häussinger, D.3
  • 80
    • 79959503376 scopus 로고    scopus 로고
    • TGR5 in the biliary tree
    • Keitel V, Häussinger D. TGR5 in the biliary tree. Dig Dis 2011;29: 45-7
    • (2011) Dig Dis , vol.29 , pp. 45-47
    • Keitel, V.1    Häussinger, D.2
  • 81
    • 79957663467 scopus 로고    scopus 로고
    • The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling
    • Li T, Holmstrom SR, Kir S, et al. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol 2011;25:1066-71
    • (2011) Mol Endocrinol , vol.25 , pp. 1066-1071
    • Li, T.1    Holmstrom, S.R.2    Kir, S.3
  • 82
    • 77956276608 scopus 로고    scopus 로고
    • Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels
    • Lavoie B, Balemba OB, Godfrey C, et al. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol 2010;588:3295-305
    • (2010) J Physiol , vol.588 , pp. 3295-3305
    • Lavoie, B.1    Balemba, O.B.2    Godfrey, C.3
  • 83
    • 0037304208 scopus 로고    scopus 로고
    • Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism
    • Marucci L, Alpini G, Glaser SS, et al. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2003;284:G290-301
    • (2003) Am J Physiol Gastrointest Liver Physiol , vol.284
    • Marucci, L.1    Alpini, G.2    Glaser, S.S.3
  • 84
    • 34347381928 scopus 로고    scopus 로고
    • Taurocholic acid feeding prevents tumor necrosis factor-Alpha-induced damage of cholangiocytes by a PI3K-mediated pathway
    • Ueno Y, Francis H, Glaser S, et al. Taurocholic acid feeding prevents tumor necrosis factor-Alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. Exp Biol Med (Maywood) 2007;232:942-9
    • (2007) Exp Biol Med (Maywood , vol.232 , pp. 942-949
    • Ueno, Y.1    Francis, H.2    Glaser, S.3
  • 85
    • 84868110731 scopus 로고    scopus 로고
    • Metabolic Syndrome and Risk of Cancer: A systematic review and meta-Analysis
    • Esposito K, Chiodini P, Colao A, et al. Metabolic Syndrome and Risk of Cancer: A systematic review and meta-Analysis. Diabetes Care 2012;35:2402-11
    • (2012) Diabetes Care , vol.35 , pp. 2402-2411
    • Esposito, K.1    Chiodini, P.2    Colao, A.3
  • 86
    • 79952072918 scopus 로고    scopus 로고
    • Metabolic syndrome and its association with colorectal cancer: A review
    • Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: A review. Am J Med Sci 2011;341:227-31
    • (2011) Am J Med Sci , vol.341 , pp. 227-231
    • Siddiqui, A.A.1
  • 87
    • 84864184031 scopus 로고    scopus 로고
    • Growth signals, inflammation, and vascular perturbations: Mechanistic links between obesity, metabolic syndrome, and cancer
    • Hursting SD, Hursting MJ. Growth signals, inflammation, and vascular perturbations: Mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol 2012; 32:1766-70
    • (2012) Arterioscler Thromb Vasc Biol , vol.32 , pp. 1766-1770
    • Hursting, S.D.1    Hursting, M.J.2
  • 88
    • 84866331749 scopus 로고    scopus 로고
    • Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation
    • Siegel AB, Lim EA, Wang S, et al. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 2012;94:539-43
    • (2012) Transplantation , vol.94 , pp. 539-543
    • Siegel, A.B.1    Lim, E.A.2    Wang, S.3
  • 89
    • 34547092697 scopus 로고    scopus 로고
    • Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes
    • Yang JI, Yoon JH, Myung SJ, et al. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun 2007;361:156-61
    • (2007) Biochem Biophys Res Commun , vol.361 , pp. 156-161
    • Yang, J.I.1    Yoon, J.H.2    Myung, S.J.3
  • 90
    • 84873294643 scopus 로고    scopus 로고
    • The deficiency of G-proteincoupled bile acid receptor gpbar1 (TGR5) enhances chemicallyinduced liver carcinogenesis
    • Chen WD, Yu D, Forman BM, et al. The deficiency of G-proteincoupled bile acid receptor gpbar1 (TGR5) enhances chemicallyinduced liver carcinogenesis. Hepatology 2013;57:656-66
    • (2013) Hepatology , vol.57 , pp. 656-666
    • Chen, W.D.1    Yu, D.2    Forman, B.M.3
  • 91
    • 58649119388 scopus 로고    scopus 로고
    • Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment
    • Kortylewski M, Xin H, Kujawski M, et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 2009;15:114-23
    • (2009) Cancer Cell , vol.15 , pp. 114-123
    • Kortylewski, M.1    Xin, H.2    Kujawski, M.3
  • 92
    • 84862798695 scopus 로고    scopus 로고
    • Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis
    • Huang C, Xie K. Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev 2012;23:25-35
    • (2012) Cytokine Growth Factor Rev , vol.23 , pp. 25-35
    • Huang, C.1    Xie, K.2
  • 93
    • 0036208350 scopus 로고    scopus 로고
    • Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line
    • Yoon JH, Higuchi H, Werneburg NW, et al. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 2002;122:985-93
    • (2002) Gastroenterology , vol.122 , pp. 985-993
    • Yoon, J.H.1    Higuchi, H.2    Werneburg, N.W.3
  • 94
    • 33846345695 scopus 로고    scopus 로고
    • Involvement of membrane-Type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-Activated protein kinases in gastric carcinoma cells
    • Yasuda H, Hirata S, Inoue K, et al. Involvement of membrane-Type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-Activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun 2007;354:154-9
    • (2007) Biochem Biophys Res Commun , vol.354 , pp. 154-159
    • Yasuda, H.1    Hirata, S.2    Inoue, K.3
  • 95
    • 84865828003 scopus 로고    scopus 로고
    • The role of bile acids in the neoplastic progression of Barrett0s esophagus-A short representative overview
    • Jürgens S, Meyer F, Spechler SJ, Souza R. The role of bile acids in the neoplastic progression of Barrett0s esophagus-A short representative overview. Z Gastroenterol 2012;50:1028-34
    • (2012) Z Gastroenterol , vol.50 , pp. 1028-1034
    • Jürgens, S.1    Meyer, F.2    Spechler, S.J.3    Souza, R.4
  • 96
    • 77149120776 scopus 로고    scopus 로고
    • Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma
    • Hong J, Behar J, Wands J, et al. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2010;59:170-80
    • (2010) Gut , vol.59 , pp. 170-180
    • Hong, J.1    Behar, J.2    Wands, J.3
  • 97
    • 84864383668 scopus 로고    scopus 로고
    • Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation
    • Casaburi I, Avena P, Lanzino M, et al. Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation. Cell Cycle 2012;11: 2699-710
    • (2012) Cell Cycle , vol.11 , pp. 2699-2710
    • Casaburi, I.1    Avena, P.2    Lanzino, M.3
  • 98
    • 34548611093 scopus 로고    scopus 로고
    • Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
    • Sato H, Genet C, Strehle A, et al. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 2007;362:793-8
    • (2007) Biochem Biophys Res Commun , vol.362 , pp. 793-798
    • Sato, H.1    Genet, C.2    Strehle, A.3
  • 99
    • 74849119709 scopus 로고    scopus 로고
    • Structure-Activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: Potential impact in diabetes
    • Genet C, Strehle A, Schmidt C, et al. Structure-Activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: Potential impact in diabetes. J Med Chem 2010;53:178-90
    • (2010) J Med Chem , vol.53 , pp. 178-190
    • Genet, C.1    Strehle, A.2    Schmidt, C.3
  • 100
    • 73249142867 scopus 로고    scopus 로고
    • Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity
    • Pellicciari R, Gioiello A, Macchiarulo A, et al. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem 2009;52: 7958-61
    • (2009) J Med Chem , vol.52 , pp. 7958-7961
    • Pellicciari, R.1    Gioiello, A.2    Macchiarulo, A.3
  • 101
    • 73249134773 scopus 로고    scopus 로고
    • Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 receptor agonists
    • Evans KA, Budzik BW, Ross SA, et al. Discovery of 3-Aryl-4- isoxazolecarboxamides as TGR5 receptor agonists. J Med Chem 2009;52:7962-5
    • (2009) J Med Chem , vol.52 , pp. 7962-7965
    • Evans, K.A.1    Budzik, B.W.2    Ross, S.A.3
  • 102
    • 75149187435 scopus 로고    scopus 로고
    • Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1
    • Perides G, Laukkarinen JM, Vassileva G, Steer ML Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1. Gastroenterology 2010;138: 715-25
    • (2010) Gastroenterology , vol.138 , pp. 715-725
    • Perides, G.1    Laukkarinen, J.M.2    Vassileva, G.3    Steer, M.L.4
  • 103
    • 84875034795 scopus 로고    scopus 로고
    • Pleiotropic functions of bile acids mediated by the farnesoid X receptor
    • Stanimirov B, Stankov K, Mikov M. Pleiotropic functions of bile acids mediated by the farnesoid X receptor. Acta Gastroenterol Belg 2012;75:389-98
    • (2012) Acta Gastroenterol Belg , vol.75 , pp. 389-398
    • Stanimirov, B.1    Stankov, K.2    Mikov, M.3
  • 104
    • 84857771313 scopus 로고    scopus 로고
    • Non-systemic drugs: A critical review
    • Charmot D. Non-systemic drugs: A critical review. Curr Pharm Des 2012;18:1434-45
    • (2012) Curr Pharm Des , vol.18 , pp. 1434-1445
    • Charmot, D.1
  • 105
    • 84880893548 scopus 로고    scopus 로고
    • Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice No additional effect of physical activity
    • Meissner M, Wolters H, de Boer RA, et al. Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity. Atherosclerosis 2013;27:964-77
    • (2013) Atherosclerosis , vol.27 , pp. 964-977
    • Meissner, M.1    Wolters, H.2    De Boer, R.A.3
  • 106
    • 79959785811 scopus 로고    scopus 로고
    • Role of bile acid sequestrants in the treatment of type 2 diabetes
    • Handelsman Y. Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 2011;34:S244-50
    • (2011) Diabetes Care , vol.34
    • Handelsman, Y.1
  • 107
    • 84874184400 scopus 로고    scopus 로고
    • A review of the efficacy and safety of oral antidiabetic drugs
    • Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf 2013;12: 153-75
    • (2013) Expert Opin Drug Saf , vol.12 , pp. 153-175
    • Stein, S.A.1    Lamos, E.M.2    Davis, S.N.3
  • 108
    • 82555189369 scopus 로고    scopus 로고
    • Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: Focus on bile acid sequestrants
    • Holst JJ, McGill MA. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: Focus on bile acid sequestrants. Clin Drug Investig 2012;32:1-14
    • (2012) Clin Drug Investig , vol.32 , pp. 1-14
    • Holst, J.J.1    McGill, M.A.2
  • 109
    • 84867574634 scopus 로고    scopus 로고
    • Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease
    • Zarrinpar A, Loomba R. Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-Alcoholic fatty liver disease. Aiment Pharmacol Ther 2012;36:909-21
    • (2012) Aiment Pharmacol Ther , vol.36 , pp. 909-921
    • Zarrinpar, A.1    Loomba, R.2
  • 110
    • 84874031840 scopus 로고    scopus 로고
    • Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
    • Potthoff MJ, Potts A, He T, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol. 2013;304: G371-80
    • (2013) Am J Physiol Gastrointest Liver Physiol , vol.304
    • Potthoff, M.J.1    Potts, A.2    He, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.